GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boston Scientific Corp (WBO:BSXC) » Definitions » ROE % Adjusted to Book Value
中文

Boston Scientific (WBO:BSXC) ROE % Adjusted to Book Value

: 2.46% (As of Dec. 2023)
View and export this data going back to 2019. Start your Free Trial

Boston Scientific's ROE % for the quarter that ended in Dec. 2023 was 10.47%. Boston Scientific's PB Ratio for the quarter that ended in Dec. 2023 was 4.25. Boston Scientific's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 2.46%.


Boston Scientific ROE % Adjusted to Book Value Historical Data

The historical data trend for Boston Scientific's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boston Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.31 -0.16 1.83 1.12 2.00

Boston Scientific Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.82 1.78 1.38 2.63 2.46

Competitive Comparison

For the Medical Devices subindustry, Boston Scientific's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boston Scientific ROE % Adjusted to Book Value Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Boston Scientific's ROE % Adjusted to Book Value falls into.



Boston Scientific ROE % Adjusted to Book Value Calculation

Boston Scientific's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=8.52% / 4.25
=2.00%

Boston Scientific's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=10.47% / 4.25
=2.46%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Boston Scientific ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Boston Scientific's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Boston Scientific (WBO:BSXC) Business Description

Address
300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Boston Scientific (WBO:BSXC) Headlines

No Headlines